gentian violet has been researched along with Astrocytoma, Grade IV in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Al Rugaie, O; Al-Shammari, AM; Kadhim, ZA; Khan, RA; Mohammed, HA; Sulaiman, GM | 1 |
Quick, QA | 1 |
Bauer, W; Fritzer-Szekeres, M; Hoechtl, T; Horvath, Z; Saiko, P; Szekeres, T; Tihan, T | 1 |
Bernshausen, A; Bieler, A; Dravits, T; Gansbacher, B; Glockzin, G; Holm, PS; Köhler-Vargas, N; Lage, H; Mantwill, K | 1 |
4 other study(ies) available for gentian violet and Astrocytoma, Grade IV
Article | Year |
---|---|
Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy.
Topics: Acridine Orange; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Chick Embryo; Emulsions; Gentian Violet; Glioblastoma; Humans; Nanoparticles; Newcastle disease virus; Oncolytic Viruses; Propidium; Rats; Solvents; Spectroscopy, Fourier Transform Infrared; Temozolomide | 2022 |
Epothilone B induces glioblastoma cell death via survivin down-regulation.
Topics: Apoptosis; Blotting, Western; Brain Neoplasms; Cell Proliferation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Epothilones; Fluorescent Antibody Technique; Gentian Violet; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Mutation; Neoplasm Proteins; Survivin; Tubulin; Tubulin Modulators; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2008 |
Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
Topics: Animals; Anti-Infective Agents, Local; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cell Line, Tumor; Chromatography, High Pressure Liquid; Coloring Agents; DNA Repair; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Gentian Violet; Glioblastoma; Glioma; Hydroxamic Acids; Oligonucleotide Array Sequence Analysis; Rats; Time Factors | 2004 |
Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520.
Topics: Adenoviridae; Antineoplastic Agents, Phytogenic; Blotting, Southern; Brain Neoplasms; Camptothecin; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Enzyme Inhibitors; Fibroblasts; Gene Deletion; Gene Expression; Gentian Violet; Glioblastoma; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunohistochemistry; Irinotecan; Oncolytic Viruses; Protein Synthesis Inhibitors; Receptors, Virus; Tumor Cells, Cultured | 2006 |